{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T01:10:06Z","timestamp":1769821806413,"version":"3.49.0"},"reference-count":101,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The EPICC peptides are a family of peptides that have been developed from the sequence of the capsid protein of human astrovirus type 1 and previously shown to inhibit the classical and lectin pathways of complement. The EPICC peptides have been further optimized to increase aqueous solubility and identify additional mechanisms of action. Our laboratory has developed the lead EPICC molecule, PA-dPEG24 (also known as RLS-0071), which is composed of a 15 amino acid peptide with a C-terminal monodisperse 24-mer PEGylated moiety. RLS-0071 has been demonstrated to possess other mechanisms of action in addition to complement blockade that include the inhibition of neutrophil-driven myeloperoxidase (MPO) activity, inhibition of neutrophil extracellular trap (NET) formation as well as intrinsic antioxidant activity mediated by vicinal cysteine residues contained within the peptide sequence. RLS-0071 has been tested in various <jats:italic>ex vivo<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> systems and has shown promise for the treatment of both immune-mediated hematological diseases where alterations in the classical complement pathway plays an important pathogenic role as well as in models of tissue-based diseases such as acute lung injury and hypoxic ischemic encephalopathy driven by both complement and neutrophil-mediated pathways (<jats:italic>i.e.<\/jats:italic>, MPO activity and NET formation). Next generation EPICC peptides containing a sarcosine residue substitution in various positions within the peptide sequence possess aqueous solubility in the absence of PEGylation and demonstrate enhanced complement and neutrophil inhibitory activity compared to RLS-0071. This review details the development of the EPICC peptides, elucidation of their dual-acting complement and neutrophil inhibitory activities and efficacy in <jats:italic>ex vivo<\/jats:italic> systems using human clinical specimens and <jats:italic>in vivo<\/jats:italic> efficacy in animal disease models.<\/jats:p>","DOI":"10.3389\/fimmu.2022.752315","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T05:40:14Z","timestamp":1644385214000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["The EPICC Family of Anti-Inflammatory Peptides: Next Generation Peptides, Additional Mechanisms of Action, and In Vivo and Ex Vivo Efficacy"],"prefix":"10.3389","volume":"13","author":[{"given":"Neel K.","family":"Krishna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji M.","family":"Cunnion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace A.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"key":"B1","first-page":"1","article-title":"Epidemiology of Human Astroviruses","volume-title":"Astrovirus Research","author":"Bosch","year":"2013"},{"key":"B2","article-title":"Astroviruses","volume-title":"Fields Virology","author":"Matsui","year":"2001"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1136\/jcp.2004.017178","article-title":"Pathology of Astrovirus Associated Diarrhoea in a Paediatric Bone Marrow Transplant Recipient","volume":"57","author":"Sebire","year":"2004","journal-title":"J Clin Pathol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1089\/vim.2005.18.17","article-title":"Identification of Structural Domains Involved in Astrovirus Capsid Biology","volume":"18","author":"Krishna","year":"2005","journal-title":"Viral Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of Two Parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"B6","article-title":"Complement System","volume-title":"Samter\u2019s Immunologic Disease","author":"Frank","year":"2001"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1923","article-title":"Complement: A Key System for Immune Surveillance and Homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/s0065-2776(08)60340-5","article-title":"The Classical Complement Pathway: Activation and Regulation of the First Complement Component","volume":"37","author":"Cooper","year":"1985","journal-title":"Adv Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.5.2950","article-title":"Evidence That Complement Protein C1q Interacts With C-Reactive Protein Through Its Globular Head Region","volume":"176","author":"McGrath","year":"2006","journal-title":"J Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1365-2567.2007.02535.x","article-title":"Studies on the Interactions Between C-Reactive Protein and Complement Proteins","volume":"121","author":"B\u00edr\u00f3","year":"2007","journal-title":"Immunology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1342","article-title":"Complement-Targeted Therapeutics","volume":"25","author":"Ricklin","year":"2007","journal-title":"Nat Biotechnol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"32251","DOI":"10.1074\/jbc.M110.149112","article-title":"Mapping Surface Accessibility of the C1r\/C1s Tetramer by Chemical Modification and Mass Spectometry Provides New Insights Into Assembly of the Human C1 Complex","volume":"285","author":"Brier","year":"2010","journal-title":"J Biol Chem"},{"key":"B13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/MOT.0b013e32834253c7","article-title":"Pentraxins (CRP, SAP) in the Process of Complement Activation and Clearance of Apoptotic Bodies Through Fc\u03b3 Receptors","volume":"16","author":"Du Clos","year":"2011","journal-title":"Curr Opin Organ Transplant"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.imbio.2012.07.004","article-title":"Interactions of the Humoral Pattern Recognition Molecule PTX3 With the Complement System","volume":"217","author":"Doni","year":"2012","journal-title":"Immunobiology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/imr.12468","article-title":"A Journey Through the Lectin Pathway of Complement-MBL and Beyond","volume":"274","author":"Garred","year":"2016","journal-title":"Immunol Rev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6161","DOI":"10.4049\/jimmunol.1401600","article-title":"The Extracellular Adherence Protein From Staphylococcus Aureus Inhibits the Classical and Lectin Pathways of Complement by Blocking Formation of the C3 Proconvertase","volume":"193","author":"Woehl","year":"2014","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1124\/pharmrev.120.000072","article-title":"Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics","volume":"73","author":"Garred","year":"2021","journal-title":"Pharmacol Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00281-017-0655-8","article-title":"Expanding Horizons in Complement Drug Discovery: Challenges and Emerging Strategies","volume":"40","author":"Harris","year":"2018","journal-title":"Semin Immunopathol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrd4657","article-title":"Complement, a Target for Therapy in Inflammatory and Degenerative Diseases","volume":"14","author":"Morgan","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170500","article-title":"Complement Activation and STAT4 Expression are Associated With Early Inflammation in Diabetic Wounds","volume":"12","author":"Cunnion","year":"2017","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-2836(83)80302-7","article-title":"Conformation and Restricted Segmental Flexibility of C1, the First Component of Human Complement","volume":"168","author":"Poon","year":"1983","journal-title":"J Mol Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1128\/JVI.01847-07","article-title":"Human Astrovirus Coat Protein Inhibits Serum Complement Activation via C1, the First Component of the Classical Pathway","volume":"82","author":"Bonaparte","year":"2008","journal-title":"J Virol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2009.10.006","article-title":"Human Astrovirus Coat Protein Binds C1q and Mbl and Inhibits the Classical and Lectin Pathways of Complement Activation","volume":"47","author":"Hair","year":"2010","journal-title":"Mol Immunol"},{"key":"B24","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-78952-1_17","article-title":"Human Astrovirus Coat Protein: A Novel C1 Inhibitor","volume-title":"Current Topics in Complement Ii","author":"Krishna","year":"2008"},{"key":"B25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.molimm.2009.10.00624","article-title":"Potent Inhibition of the Classical Pathway of Complement by a Novel C1q-Binding Peptide Derived From the Human Astrovisus Coat Protein","volume":"48","author":"Gronemus","year":"2010","journal-title":"Mol Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.10.3898","article-title":"Inhibition of Hemolytic Activity of the First Component by Human Neutrophil Defensins","volume":"92","author":"van den Berg","year":"1998","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1128\/JVI.02666-15","article-title":"Structural, Mechanistic, and Antigenic Characterization of the Human Astrovirus Capsid","volume":"90","author":"York","year":"2015","journal-title":"J Virol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1256070","DOI":"10.1126\/science.1256070","article-title":"Intracellular Sensing of Complement C3 Activates Cell Autonomous Immunity","volume":"345","author":"Tam","year":"2015","journal-title":"Science"},{"key":"B29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.molimm.2012.07.012","article-title":"A Novel Peptide Inhibitor of Classical and Lectin Complement Activation Including ABO Incompatability","volume":"53","author":"Mauriello","year":"2013","journal-title":"Mol Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00406","article-title":"Peptide Inhibitor of Complement C1, a Novel Suppressor of Classical Pathway Activation: Mechanistic Studies and Clinical Potential","volume":"5","author":"Sharp","year":"2014","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132446","article-title":"Peptide Inhibitor of Complement C1 (PIC1) Rapidly Inhibits Complement Activation After Intravascular Injection in Rats","volume":"10","author":"Sharp","year":"2015","journal-title":"PloS One"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.9.5710","article-title":"Identification of the Site of Human Mannan-Binding Lectin Involved in the Interaction With its Partner Serine Proteases: The Essential Role of Lys55","volume":"178","author":"Teillet","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102109","article-title":"The Many Roles of Myeloperoxidase: From Inflammation and Immunity to Biomarkers, Drug Metabolism and Drug Discovery","volume":"46","author":"Siraki","year":"2021","journal-title":"Redox Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(93)90010-t","article-title":"Studies on the Chlorinating Activity of Myeloperoxidase","volume":"251","author":"Harrison","year":"1976","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/0006-2952(93)90010-t","article-title":"Superoxide Is an Antagonist of Anti-Inflammatory Drugs That Inhibit Hypochlorous Acid Production by Myeloperoxidase","volume":"45","author":"Kettle","year":"2003","journal-title":"Biochem"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170203","article-title":"Inhibition of Myeloperoxidase Activity in Cystic Fibrosis Sputum by Peptide Inhibitor of Complement C1 (Pic1)","volume":"12","author":"Hair","year":"2017","journal-title":"PloS One"},{"key":"B37","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.toxlet.2005.03.004","article-title":"Free Heme Toxicity and its Detoxification Systems in Humans","volume":"157","author":"Kumar","year":"2005","journal-title":"Toxicol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a013433","article-title":"Cell-Free Hemoglobin and its Scavenger Proteins: New Disease Models Leading the Way to Targeted Therapies","volume":"3","author":"Schaer","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9454583","article-title":"Peptide Inhibitor of Complement C1 Inhibits the Peroxidase Activity of Hemoglobin and Myoglobin","volume":"2017","author":"Hair","year":"2017","journal-title":"Int J Pept"},{"key":"B40","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.redox.2013.01.014","article-title":"Teaching the Basics of Redox Biology to Medical and Graduate Students: Oxidants, Antioxidants and Disease Mechanisms","volume":"1","author":"Kalyanaraman","year":"2013","journal-title":"Redox Biol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.redox.2015.08.020","article-title":"Reperfusion Injury and Reactive Oxygen Species: The Evolution of a Concept","volume":"6","author":"Granger","year":"2015","journal-title":"Redox Biol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.freeradbiomed.2011.02.011","article-title":"Postoperative Acute Kidney Injury Associated With Hemoglobinemia and an Enhanced Oxidative Stress Response","volume":"50","author":"Billings","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193931","article-title":"Peptide Inhibitor of Complement C1 (PIC1) Demonstrates Antioxidant Activity via Single Electron Transport (SET) and Hydrogen Atom Transfer (HAT)","volume":"13","author":"Gregory Rivera","year":"2018","journal-title":"PloS One"},{"key":"B44","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1016\/j.bbagen.2012.09.018","article-title":"Glutathione Catalysis and the Reaction Mechanisms of Glutathione-Dependent Enzymes","volume":"1830","author":"Deponte","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B45","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/BOR.0b013e3283546703","article-title":"Lupus Neutrophils: \u2018Net\u2019 Gain in Understanding Lupus Pathogenesis","volume":"24","author":"Knight","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.18388\/abp.2013_1983","article-title":"Neutrophil Extracellular Traps (NETs) \u2013 Formation and Implications","volume":"60","author":"Zawrotniak","year":"2013","journal-title":"Acta Biochim Pol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nm.4027","article-title":"Neutrophil Extracellular Traps Enriched in Oxidized Mitochondrial DNA are Interferogenic and Contribute to Lupus-Like Disease","volume":"22","author":"Lood","year":"2016","journal-title":"Nat Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-020-08804-7","article-title":"A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NET Therapeutics","volume":"1","author":"Mutua","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042984","article-title":"Influences of Chloride and Hypochlorite on Neutrophil Extracellular Trap Formation","volume":"7","author":"Akong-Moore","year":"2012","journal-title":"PloS One"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00558","article-title":"Inhibition of Immune Complex Complement Activation and Neutrophil Extracellular Trap Formation by Peptide Inhibitor of Complement C1","volume":"9","author":"Hair","year":"2018","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226875","article-title":"Inhibition of Complement Activation, Myeloperoxidase, NET Formation and Oxidant Activity by PIC1 Peptide Variants","volume":"14","author":"Hair","year":"2019","journal-title":"PloS One"},{"key":"B52","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/bip.20560","article-title":"N-Methylation of N(alpha)-Acylated, Fully C(alpha)-Methylated, Linear, Folded Peptides: Synthetic and Conformational Aspects","volume":"84","author":"Moretto","year":"2006","journal-title":"Biopolymers"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f4303","article-title":"Transfusing Blood Safely and Appropriately","volume":"347","author":"Murphy","year":"2013","journal-title":"BMJ"},{"key":"B54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev-pathol-012414-040318","article-title":"Pathobiology of Transfusion Reactions","volume":"10","author":"Zimring","year":"2015","journal-title":"Annu Rev Pathol"},{"key":"B55","first-page":"493","article-title":"Pretransfusion Testing","volume-title":"AABB Technical Manual","author":"Downes","year":"2011"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13948","article-title":"Discriminating the Hemolytic Risk of Blood Type A Plasmas Using the Complement Hemolysis Using Human Erythrocytes (CHUHE) Assay","volume":"57","author":"Cunnion","year":"2017","journal-title":"Transfusion"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13592","article-title":"Discriminating Complement-Mediated Acute Transfusion Reaction for Type O+ RBCs Transfused Into a B+ Recipient With the Complement Hemolysis Using Human Erythrocytes (CHUHE) Assay","volume":"56","author":"Cunnion","year":"2016","journal-title":"Transfusion"},{"key":"B58","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/trf.12695","article-title":"Complement Inhibition Significantly Decreases Red Blood Cell Lysis in a Rat Model of Acute Intravascular Hemolysis","volume":"54","author":"Shah","year":"2014","journal-title":"Transfusion"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1111\/trf.13674","article-title":"Peptide Inhibitor of Complement C1 Modulates Acute Intravascular Hemolysis of Mismatched Red Blood Cells in Rats","volume":"56","author":"Kumar","year":"2016","journal-title":"Transfusion"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1159\/000154811","article-title":"Hemolytic Transfusion Reactions","volume":"35","author":"Strobel","year":"2008","journal-title":"Transfus Med Hemother"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1182\/blood-2018-02-785964","article-title":"How I Safely Transfuse Patients With Sickle-Cell Disease and Manage Delayed Hemolytic Transfusion Reactions","volume":"131","author":"Pirenne","year":"2018","journal-title":"Blood"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1016\/S0140-6736(15)01313-6","article-title":"Transfusion Reactions: Prevention, Diagnosis, and Treatment","volume":"388","author":"Delaney","year":"2016","journal-title":"Lancet"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.14740\/jh553","article-title":"Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease and the Role of the Classical Complement Pathway: A Case Report","volume":"10","author":"Hair","year":"2021","journal-title":"J Hematol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03321.x","article-title":"Serologic Characteristics of Ceftriaxone Antibodies in 25 Patients With Drug Induced Immune Hemolytic Anemia (CME)","volume":"52","author":"Arndt","year":"2011","journal-title":"Transfusion"},{"key":"B65","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1177\/1060028015580345","article-title":"Ceftriaxone Induced Immune Hemolytic Anemia","volume":"49","author":"Neuman","year":"2015","journal-title":"Annal Pharmacotherapy"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4105653","article-title":"Ceftriaxone-Induced Immune Hemolytic Anemia: In Vitro Reversal With Peptide Inhibitor of Complement C1 (Pic1)","volume":"2019","author":"Cunnion","year":"2019","journal-title":"Case Rep Hematol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/bjh.13597","article-title":"Platelet Refractoriness\u2013Practical Approaches and Ongoing Dilemmas in Patient Management","volume":"171","author":"Stanworth","year":"2015","journal-title":"Br J Haematol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1111\/trf.13598","article-title":"C1q-Binding Anti-HLA Antibodies do Not Predict Platelet Transfusion Failure in Trial to Reduce Alloimmunization to Platelets Study Participants","volume":"56","author":"Jackman","year":"2016","journal-title":"Transfusion"},{"key":"B69","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molimm.2020.05.008","article-title":"A Complement-Mediated Rat Xenotransfusion Model of Platelet Refractoriness","volume":"124","author":"Enos","year":"2020","journal-title":"Mol Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.autrev.2013.02.001","article-title":"Management of Immune Cytopenias in Patients With Systemic Lupus Erythematosus \u2013 Old and New","volume":"12","author":"Newman","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160340","article-title":"Comparison of Disease Characteristics, Organ Damage, and Survival in Patients With Juvenile-Onset and Adult-Onset Systemic Lupus Erythematosus in a Combined Cohort From 2 Tertiary Centers in Turkey","volume":"44","author":"Artim-Esen","year":"2017","journal-title":"J Rheumatol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/01.md.0000224709.70133.f7","article-title":"Predictors of Survival in Systemic Lupus Erythematosus","volume":"85","author":"Kasitanon","year":"2006","journal-title":"Med (Baltimore)"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320936347","article-title":"Classical Complement Activation on Human Erythrocytes in Subjects With Systemic Lupus Erythematosus and a History of Autoimmune Hemolytic Anemia","volume":"29","author":"Hair","year":"2020","journal-title":"Lupus"},{"key":"B74","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1164\/ajrccm.152.2.7633718","article-title":"Increased Degranulation of Eosinophil and Neutrophil Granulocytes in Cystic Fibrosis","volume":"152","author":"Koller","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"B75","first-page":"711","article-title":"Purification and Cytotoxic Potential of Myeloperoxidase in Cystic Fibrosis Sputum","volume":"112","author":"Mohammed","year":"1988","journal-title":"J Lab Clin Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"378","DOI":"10.2337\/dc06-1383","article-title":"Bacterial Load Predicts Healing Rate in Neuropathic Diabetic Foot Ulcers","volume":"30","author":"Xu","year":"2007","journal-title":"Diabetes Care"},{"key":"B77","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/j.1464-5491.2006.01773.x","article-title":"The Molecular Biology of Chronic Wounds and Delayed Healing in Diabetes","volume":"23","author":"Blakytny","year":"2006","journal-title":"Diabetes Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/398412","article-title":"Shedding Light on a New Treatment for Diabetic Wound Healing: A Review on Phototherapy","volume":"2014","author":"Houreld","year":"2014","journal-title":"Sci World J"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2010.05.010","article-title":"Epidemiology of Neonatal Encephalopathy and Hypoxic-Ischaemic Encephalopathy","volume":"86","author":"Kurinczuk","year":"2010","journal-title":"Early Hum Dev"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2016.271","article-title":"Therapeutic Hypothermia Modulates Complement Factor C3a and C5a Levels in a Rat Model of Hypoxic Ischemic Encephalopathy","volume":"81","author":"Shah","year":"2017","journal-title":"Pediatr Res"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003311.pub3","article-title":"Cooling for Newborns With Hypoxic Ischaemic Encephalopathy","volume":"1","author":"Jacobs","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2012.09.008","article-title":"Hypoxic-Ischemic Encephalopathy and Novel Strategies for Neuroprotection","volume":"39","author":"Shankaran","year":"2012","journal-title":"Clin Perinatol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cca.2006.06.010","article-title":"Complement Mediators in Ischemia-Reperfusion Injury","volume":"374","author":"Arumugam","year":"2006","journal-title":"Clin Chim Acta"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000182237.20807.d0","article-title":"C1q-Deficiency is Neuroprotective Against Hypoxic-Ischemic Brain Injury in Neonatal Mice","volume":"36","author":"Ten","year":"2005","journal-title":"Stroke"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1523\/jneurosci","article-title":"Complement Component C1q Mediates Mitochondria-Driven Oxidative Stress in Neonatal Hypoxic-Ischemic Brain Injury","volume":"30","author":"Ten","year":"2010","journal-title":"J Neurosci"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2011.01.108","article-title":"Hypoxic-Ischemic Brain Injury Stimulates Inflammatory Response and Enzymatic Activities in the Hippocampus of Neonatal Rats","volume":"1388","author":"Pimentel","year":"2011","journal-title":"Brain Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257960","article-title":"Classical Complement Pathway Inhibition Reduces Brain Damage in a Hypoxic Ischemic Encephalopathy Animal Model","volume":"16","author":"Kumar","year":"2021","journal-title":"PloS One"},{"key":"B88","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1101\/lm.046300.117","article-title":"A Barnes Maze for Juvenile Rats Delineates the Emergence of Spatial Navigation Ability","volume":"25","author":"McHail","year":"2018","journal-title":"Learn Mem"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1002\/0471141755.ph0559s49","article-title":"Novel Object Recognition in the Rat: A Facile Assay for Cognitive Function","author":"Mathiasen","year":"2010","journal-title":"Curr Protoc Pharmacol"},{"key":"B90","article-title":"Transfusion-Related Acute Lung Injury","volume-title":"StatPearls","author":"Cho","year":"2021"},{"key":"B91","article-title":"Ventilator-Induced Lung Injury (VILI)","volume-title":"StatPearls","author":"Kumar","year":"2020"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01626","article-title":"Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19","volume":"11","author":"Polidoro","year":"2020","journal-title":"Front Immunol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4187\/respcare.04716","article-title":"Past and Present ARDS Mortality Rates: A Systematic Review","volume":"62","author":"Maca","year":"2017","journal-title":"Respir Care"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2013-0485TR","article-title":"Complement System in Lung Disease","volume":"51","author":"Pandya","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2014.01.005","article-title":"Complement Components as Potential Therapeutic Targets for Asthma Treatments","volume":"108","author":"Khan","year":"2014","journal-title":"Respir Med"},{"key":"B96","doi-asserted-by":"publisher","first-page":"6335","DOI":"10.1182\/blood-2012-01-405183","article-title":"Extracellular DNA Traps Are Associated With the Pathogenesis of TRALI in Humans and Mice","volume":"119","author":"Thomas","year":"2012","journal-title":"Blood"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1172\/JCI61303","article-title":"Platelets Induce Neutrophil Extracellular Traps in Transfusion-Related Acute Lung Injury","volume":"122","author":"Caudrillier","year":"2012","journal-title":"J Clin Invest"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0259133","article-title":"Peptide Inhibition of Acute Lung Injury in a Novel Two-Hit Rat Model","volume":"16","author":"Sampson","year":"2021","journal-title":"PloS One"},{"key":"B99","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00251-006-0142-1","article-title":"Genomic View of the Evolution of the Complement System","volume":"58","author":"Nonaka","year":"2006","journal-title":"Immunogenetics"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01117","article-title":"Complement Evasion Strategies of Viruses: An Overview","volume":"8","author":"Agrawal","year":"2017","journal-title":"Front Microbiol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/biom8030077","article-title":"Membrane Active Peptides and Their Biophysical Characterization","volume":"8","author":"Avci","year":"2018","journal-title":"Biomolecules"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.752315\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T05:40:23Z","timestamp":1644385223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.752315\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,9]]},"references-count":101,"alternative-id":["10.3389\/fimmu.2022.752315"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.752315","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,9]]},"article-number":"752315"}}